Skip to main content
×
×
Home

Pharmacotherapy of Social Phobia: A Controlled Study with Moclobemide and Phenelzine

  • M. Versiani (a1), A. E. Nardi (a1), F. D. Mundim (a1), A. B. Alves (a2), M. R. Liebowitz (a3) and R. Amrein (a4)...
Abstract

In a double-blind, parallel group trial, 78 subjects with social phobia received moclobemide (a new reversible inhibitor of monoamine oxidase A) phenelzine, or placebo. After eight weeks, both active drugs – phenelzine somewhat more than moclobemide – were clinically and statistically significantly more effective than placebo, as assessed by rating scales. There was some further improvement between weeks 8 and 16, particularly in the moclobemide group; at week 16, 82% of the moclobemide and 91% of the phenelzine-treated patients were almost asymptomatic. Moclobemide was, however, much better tolerated than phenelzine. Patients withdrawn from active drugs had relapsed by week 24, providing additional support for the efficacy of the active drugs.

Copyright
Corresponding author
Av. N. Sa. Copacabana, 1133/1303, CEP 22070, Rio de Janeiro-RJ, Brazil
References
Hide All
Amies, P. L., Gelder, M. G. & Shan, P. M. (1983) Social phobia: a comparative clinical study. British Journal of Psychiatry, 142, 174179.
American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd edn) (DSM–III). Washington, DC: APA.
American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM–III–R). Washington, DC: APA.
Baldessarini, R. J. (1989) Current status of antidepressants: clinical pharmacology therapy. Journal of Clinical Psychiatry, 50, 117126.
Baumhackl, U., Biziere, K., Fischbach, F., et al (1989) Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM–III): an Austrian double-blind, multi centre study. British Journal of Psychiatry, 155 (suppl. 6): 7883.
Brady, J. P. (1984a) Social skills training for psychiatric patients: international concepts, methods and clinical results. American Journal of Psychiatry, 141, 333340.
Brady, J. P. (1964b) Social skills training for psychiatric patients: II. Clinical outcome studies. American Journal of Psychiatry, 141, 491498.
Callingham, B. A. & Ovens, R. S. (1987) Some in vitro effects of moclobemide and other MAO inhibitors on responses to sympathomimetic amines. Journal of Neural Transmission, 26, 1729.
Derogatis, L. R., Lipman, R. S. & Covi, L. (1973) SCL–90: An out patient psychiatric rating scale. Psychopharmacological Bulletin, 9, 1328.
Emmelkamp, P. M. G. (1982) Phobic and Obsessive–Compulsive Disorder: Theory, Research and Practice. New York: Plenum Press.
Finberg, J. P. M. & Youdim, M. B. H. (1987) Potentiation of tyramine pressor responses in conscious rats by reversible inhibitors of monoamine oxidase. Journal of Neural Transmission, 26, 1116.
Gieschke, R., Schmid-Burgk, W. & Amrein, R. (1987) Interaction of moclobemide, a new reversible monoamine oxidase inhibitor with oral tyramine. Journal of Neural Transmission, 26, 97104.
Goldstein, S. (1987) Treatment of social phobia with clonidine. Biological Psychiatry, 22, 369372.
Gorman, J. M., Liebowitz, M. R., Fyer, A. J., et al (1985) Treatment of social phobia with atenolol. Journal of Clinical Psychopharmacology, 5, 298301.
Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology, revised. Rockville, Maryland: US Dept of Health, Education and Welfare.
Hamilton, M. (1959) The assessment of anxiety scales by rating. British Journal of Medical Psychology, 32, 5055.
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 5662.
Heinze, G. & Sanchez, A. (1987) El moclobemide en lo tratamiento de la depression. Salud Mental, 10, 2935.
Klein, D. (1983) Is the antipanic activity of antidepressant medication a reflection of antidepressant effects? Integrative Psychiatry, 1, 2627.
Larsen, J. K., Holm, P. & Mikkelsen, P. L. (1984) Moclobemide and clomipramine in the treatment of depression. Acta Psychiatrica Scandinavica, 70, 252260.
Liebowitz, M. R., Gorman, J. M., Fyer, A. J., et al (1985) Social phobia. Review of a neglected anxiety disorder. Archives of General Psychiatry, 42, 729736.
Liebowitz, M. R., Fyer, A. J., Gorman, J. M., et al (1986) Phenelzine in social phobia. Journal of Clinical Psychopharmacology, 6, 9398.
Liebowitz, M. R., Gorman, J. M., Fyer, A. J., et al (1988) Pharmacotherapy of social phobia: an interim report of a placebo-controlled comparison of phenelzine and atenolol. Journal of Clinical Psychiatry, 49, 252257.
Lydiard, R. B., Laraia, M. T., Howell, E. D., et al (1988) Alprazolam in the treatment of social phobia. Journal of Clinical Psychiatry, 49, 1719.
Marks, I. M. (1981) Cure and Care of Neurosis. New York: Wiley.
Mountjoy, C. Q., Roth, M., Garside, R. F., et al (1977) A clinical trial of phenelzine in anxiety depressive and phobic neuroses. British Journal Psychiatry, 131, 486492.
Munjack, D. J., Baltazar, P. L., Bohn, P. B., et al (1990) Clonazepam in the treatment of social phobia: a pilot study. Journal of Clinical Psychiatry, 51 (suppl. 5): 3540.
Norman, T. R., Ames, D. & Burrows, G. D. (1985) A controlled study of a specific MAO-A reversible inhibitor and amitriptyline in depressive illness. Journal of Affective Disorders, 8, 2938.
Ost, L. G., Jerremalm, A. & Johanson, J. (1980) Individual response patterns and the effects of different behavioural methods in the treatment of social phobia. Behavioural Research and Therapy, 19, 116.
Sheehan, D. (1984) In The Anxiety Disease, pp. 148149. New York: Scribner.
Solyom, C., Solyom, L., Lapierre, Y., et at (1981) Phenelzine and exposure in the treatment of phobia. Biological Psychiatry, 16, 239247.
Solyom, C., Heseltine, G. F. D., McClure, D. J., et al (1973) Behavior therapy versus drug therapy in the treatment of phobic neurosis. Canadian Journal of Psychiatry, 18, 2531.
Solyom, C., Ledwige, B. & Solyom, C. (1986) Delimiting social phobia. British Journal of Psychiatry, 149, 464470.
Spitzer, R., Williams, J. B. & Gibbon, M. (1987) Structured Clinical Interview of DSM–III–R (SCID I and II). Biometrics Research Department, New York Psychiatric Institute.
Stabl, M., Biziere, K., Schmid-Burgk, W., et al (1989) Review of comparative clinical trials: moclobemide vs tricyclic antidepressants and vs placebo in depressive states. Journal of Neural Transmission, (suppl. 28), 7790.
Stefanis, C. N., Alevizos, B. & Papadimitriou, M. (1984) Controlled clinical study of moclobemide. A new MAO inhibitor and desipramine in depressive patients. In Monoamine Oxidase and Disease (ed. Tipton, K. F.). London: Academic Press.
Stravynski, A. & Shahar, A. (1983) The treatment of social dysfunction in nonpsychotic outpatients: a review. Journal of Nervous and Mental Disease, 171, 721728.
Tyrer, P. J., Candy, J. & Jelly, D. (1973) A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety. Psychopharmacology, 32, 237254.
Versiani, M. (1990) Social phobia and pharmacotherapy. Human Psychopharmacology, 5, 103104.
Versiani, M., Mundim, F. D., Nardi, A. E., et al (1988) Tranylcypromine in social phobia. Journal of Clinical Psychopharmacology, 8, 279283.
Versiani, M., Nardi, A. E. & Mundim, F. D. (1989a) Fobia social. Jornal Brasileiro de Psiquiatria, 38, 251263.
Versiani, M., Oggero, U., Alterwain, P., et al (1989b) A double-blind comparative trial of moclobemide vs imipramine and placebo in major depressive episodes. British Journal of Psychiatry, 155 (suppl. 6): 7277.
Versiani, M., Nardi, A. E., Figueira, I. L. V., et al (1990) Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo. Acta Psychiatrica Scandinavica, (suppl. 360), 2428.
Watson, D. & Friend, R. (1969) Measurement of social–evaluative anxiety. Journal of Consulting and Clinical Psychology, 33, 448457.
Willouohby, R. R. (1932) Some properties of the Thurstone Personality Schedule and a suggested revision. Journal of Social Psychology, 3, 401424.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Pharmacotherapy of Social Phobia: A Controlled Study with Moclobemide and Phenelzine

  • M. Versiani (a1), A. E. Nardi (a1), F. D. Mundim (a1), A. B. Alves (a2), M. R. Liebowitz (a3) and R. Amrein (a4)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *